Home > Boards > Free Zone > User's Groups > Winners Circle

good news for INSM

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
hunter1 Member Profile
 
Followed By 1
Posts 69
Boards Moderated 1
Alias Born 02/11/04
160x600 placeholder
Trump Signs Off on Deal Allowing TikTok to Continue U.S. Operations--5th Update
WASHINGTON -- President Trump said he has agreed in concept to a deal under which Chinese-owned video-sharing app TikTok will partner with Oracle Corp. and Walmart Inc. to become a U.S.-based company, capping negotiations that have stirred debate over national security and the future of the internet.
TikTok Files Another Lawsuit to Block Ban on App -- Update
Trump Signs Off on Deal Allowing TikTok to Continue U.S. Operations--4th Update
Trump Signs Off on Deal Allowing TikTok to Continue U.S. Operations--3rd Update
Trump Signs Off on Deal Allowing TikTok to Continue U.S. Operations--Update
Trump Signs Off on Deal Allowing TikTok to Continue U.S. Operations
TikTok Files Another Lawsuit to Block Ban on App
New Crop of Covid-Tracking Apps Addresses Old Concerns
Alibaba and Tencent Kick the Tires on a New Idea -- Keeping China's Jalopies on the Road
How to Think Long Term With Near-Zero Interest Rates
Correction to Midwest Coronavirus Case Numbers Article on Sept. 18
The Incredible Shrinking GM -- WSJ
Oracle, Snowflake, SoftBank: Stocks That Defined the Week -- WSJ
Exchange Eyes Sale Of Italian Operation -- WSJ
Six Charged With Bribing Amazon Workers -- WSJ
Keywords: Moore's Law Is Dead. Long Live Huang's Law. -- WSJ
What's News: Business & Finance -- WSJ
Companies' New Back-to-Work Dilemma: Who Comes First?
How a Styling Executive Fashioned His Path to the Top
Huang's Law Is the New Moore's Law, and Explains Why Nvidia Wants Arm
U.S. to Ban TikTok, WeChat Downloads on Sunday -- 11th Update
hunter1   Thursday, 10/05/06 08:17:17 AM
Re: None
Post # of 24977 
good news for INSM

http://www.marketwatch.com/News/Story/Story.aspx?guid=%7B2AFB6779%2DF1AF%2D43E9%2D8CF3%2DF72D28ABD46...

Insmed Provides Update Concerning Virginia Unfair Competition Litigation

PrintE-mailDisable live quotesRSSDigg itDel.icio.usLast Update: 6:42 PM ET Oct 4, 2006


RICHMOND, Va., Oct 04, 2006 /PRNewswire via COMTEX/ -- Insmed Incorporated announced today that the U.S. District Court for the Eastern District of Virginia granted in part Insmed's motion to dismiss unfair competition claims brought against Insmed by Tercica, Inc. In a ruling today, Chief United States District Judge James R. Spencer narrowed the scope of Tercica's lawsuit against Insmed. In dismissing portions of the claims brought by Tercica, the Court found areas in which Tercica had not met its burden of establishing that the alleged statements made by Insmed constituted "false advertising" or violated Virginia law. While the court held that a number of Tercica's other factual allegations, if proven, would state claims for false advertising under federal and California law, in comments at the September 9 hearing, Judge Spencer noted that he felt "most if not all" of Tercica's case "could go out on summary judgment."
About IPLEX
IPLEX is approved in the United States as the only once daily treatment for children with short stature associated with severe primary IGF-I deficiency (Primary IGFD). IPLEX, a complex of recombinant human IGF-I and its binding protein IGFBP-3 (rhIGF-I/rhIGFBP-3), is the only FDA-approved IGF- I replacement therapy that also replaces deficient IGFBP-3 in these patients. The drug, which was launched in the second quarter of 2006, is also being investigated for various other indications with unmet medical needs, including severe insulin resistance, myotonic muscular dystrophy and HIV Associated Adipose Redistribution Syndrome (HARS). For more information about IPLEX please go to http://www.go-IPLEX.com.
About Insmed


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences